SCHEMBL20767253

SCHEMBL20767253

CCOc1ccc(CNCc2cccc(F)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.57
TP53 P04637 1/20 0.57
POLB P06746 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.54
KDM4E B2RXH2 1/20 0.53
LMNA P02545 1/20 0.53
PLA2G1B P04054 1/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
ATG4B Q9Y4P1 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAOB P27338 4/20 0.51
CACNA2D1 P54289 1/20 0.50
SCN8A Q9UQD0 1/20 0.50
MAPK1 P28482 1/20 0.50
MAOA P21397 1/20 0.49
SCN9A Q15858 1/20 0.49
BCHE P06276 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20767219 0.84 LMNA (0.63) ALDH1A1TP53POLBTDP1LMNA
SCHEMBL22874674 0.81 MAOB (0.71) ALDH1A1TP53SMN1; SMN2KDM4ELMNA
SCHEMBL20767235 0.81 MEN1 (0.48) ALDH1A1SMN1; SMN2KDM4ELMNAGAA
SCHEMBL20766940 0.79 MAPK1 (0.55) ALDH1A1TP53POLBTDP1KDM4E
SCHEMBL21165344 0.78 MPO (0.57) POLBTDP1MEN1KMT2AMAOB
SCHEMBL30753812 0.77 MPO (0.55) MAOBSCN8AMAOA
SCHEMBL2720282 0.77 MPO (0.55) MAOBSCN8AMAOA
SCHEMBL28207660 0.76 CHRM2 (0.62) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL20804366 0.76 MPO (0.54) MAOBSCN8AMAOA
SCHEMBL11482232 0.76 MAOB (0.56) SMN1; SMN2KDM4EMAOBSCN8AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed
WO-2019040105-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed